What can we learn from different ways of treating patients with Von Willebrand Disease (VWD)? And how can we ensure that every patient receives personalized treatment?

Join national and international experts in the upcoming live webinar on Thursday, June 1st at 3.30 pm CET. Don’t miss this opportunity to learn more about different treatment approaches and the role of prophylaxis in severe VWD.

What can we learn from different ways of treating patients with Von Willebrand Disease (VWD)?
And how can we ensure that every patient receives personalized treatment?

Join national and international experts in the upcoming live webinar on Thursday, June 1st at 3.30 pm CET. Don’t miss this opportunity to learn more about different treatment approaches and the role of prophylaxis in severe VWD.

Experts
Prof. dr. Frank Leebeek, Hematologist and Department Head of Hematology at Erasmus University Medical Center, The Netherlands
Dr. Saskia Schols, Hematologist at Radboud University Medical Center, The Netherlands
Prof. dr. Sophie Susen, Hematologist and Director of the Department of Haemostasis and Transfusion at Lille University Hospital in Lille, France
Prof. dr. Wolfgang Miesbach, Hematologist and Head coagulation disorders and comprehensive care center at University Hospital Frankfurt, Germany

Program
3.30 pm Welcome by chair
Prof. dr. Frank Leebeek

3.40 pm Independent dosing of VWF and FVIII (The Dutch experience)
Dr. Saskia Schols

4.00 pm Independent dosing of VWF and FVIII (The French experience)
Prof. dr. Sophie Susen

4.20 pm The role of prophylaxis in clinically severe VWD
Prof. dr. Wolfgang Miesbach

4.50 pm Patient cases

5.20 pm Q&A

5.30 pm Closure
Prof. dr. Frank Leebeek